Skip to content

Effect of 980nm Diode Laser on Postoperative Pain and Root Canal Disinfection in Endodontic Retreatment Cases

Unknown statusNot applicableNCT03711357
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

A randomized clinical trial that evaluates the effect of using 980nm diode laser intracanal irradiation on postoperative pain and root canal disinfection in endodontic retreatment cases with chronic periapical lesions

Study details

Official title
Evaluation of the Effect of 980nm Diode Laser Intracanal Irradiation on Postoperative Pain and Root Canal Disinfection in Endodontic Retreatment Cases With Chronic Periapical Lesions
Interventions
Sponsor
Cairo University
Start date
2018-10
Primary completion
2020-05
Sex
All
Age range
from 18 Years to 50 Years
Healthy volunteers
true
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Endodontic retreatment cases of single rooted teeth with chronic periapical lesions; with periapical radiolucency of less than 1 cm diameter will be selected. 2. Teeth with straight root canals. 3. Subjects aged between 18-50 years of age. 4. No contributory medical history. 5. No previous administration of analgesics and / or antibiotics within the previous 2 weeks. Exclusion Criteria: 1. Retreatment cases with complications such as separated instruments, perforations, ledges, resorption, transportation, calcifications, immature apices and over fillings. 2. Teeth with curved roots. 3. Swelling or sinus tract. 4. Mutilated teeth that interfere with proper isolation and seal between visits. 5. Subjects with generalized periodontitis, or if the tooth has probing depth of more than 3 mm. 6. Subjects with uncontrolled diabetes or debilitating diseases. 7. Pregnant or nursing females. 8. Systemic disorders that necessitate antibiotic prophylaxis or prevent the use of Ibuprofen.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03711357